Skip to main content
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Care

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Care
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • Special Article Collections
    • ADA Standards of Medical Care
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • Special Article Collections
    • ADA Standards of Medical Care
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Clinical Care/Education/Nutrition

Measuring Habitual Walking Speed of People With Type 2 Diabetes

Are they meeting recommendations?

  1. Steven T. Johnson, MSC1,
  2. Catrine Tudor-Locke, PHD2,
  3. Linda J. McCargar, PHD, RD1 and
  4. Rhonda C. Bell, PHD1
  1. 1Department of Agricultural, Food and Nutritional Science, University of Alberta, Edmonton, Alberta, Canada
  2. 2Department of Exercise and Wellness, Arizona State University East, Mesa, Arizona
  1. Address correspondence and reprint requests to Steven T. Johnson, MSC, Department of Agricultural, FoodNutritional Science, 4-10 Agriculture Forestry Centre, Edmonton, Alberta, Canada T6G 2P5. E-mail: stevej{at}ualberta.ca
Diabetes Care 2005 Jun; 28(6): 1503-1504. https://doi.org/10.2337/diacare.28.6.1503
PreviousNext
  • Article
  • Figures & Tables
  • Info & Metrics
  • PDF
Loading

Are they meeting recommendations?

  • AMP, activity monitoring pod
  • FSP, First Step Program

Revised physical activity guidelines for individuals with type 2 diabetes recommend at least 150 min/week of moderate-intensity aerobic physical activity (40–60% of Vo2max or 50–70% of maximum heart rate) and/or 90 min/week of aerobic exercise (>60% of Vo2max or >70% of maximum heart rate) (1). In a structured exercise program or in the laboratory setting, levels of physical activity can be closely monitored; however, self-directed walking is the most common and most acceptable form of physical activity (2,3) to people with type 2 diabetes, and little is known about self-paced walking speed (and therefore intensity). A walking speed of 4.0 km/h is widely accepted as moderately intense physical activity (4). Numerous studies examining the beneficial effects of physical activity for people with type 2 diabetes exist (rev. in 1,5). Few, however, have directly measured walking speed.

Previous research (6,7) demonstrated efficacy in increasing physical activity of participants using the First Step Program (FSP), a pedometer-based, self-paced walking program designed to help people with type 2 diabetes increase their steps per day. Despite the increase in physical activity, improvements in health outcomes were modest. In contrast, the implementation of the FSP in a worksite setting involving healthy adults resulted in significant reductions in weight, BMI, waist girth, and resting heart rate (8). We hypothesize that a slower walking speed in the people with type 2 diabetes may contribute to the smaller improvements in health-related outcomes in this population. Therefore, the objective of this study was to determine self-paced walking speed and other characteristics of ambulation in a group of people with type 2 diabetes who had recently completed the FSP.

RESEARCH DESIGN AND METHODS

A convenience sample of 19 participants with type 2 diabetes (11 men, 8 women) were recruited after they had completed the FSP, a 16-week pedometer-based lifestyle program for individuals with type 2 diabetes designed to increase steps per day. Eligible participants were diagnosed with type 2 diabetes, aged 40–70 years, not taking insulin, without physical limitations, not currently enrolled in another physical activity program, and accumulating <8,800 pedometer-determined steps/day. The 3-day average pedometer-determined physical activity following the FSP was 9,344 steps/day.

Ambulation data were collected by participants wearing an Activity Monitoring Pod 331 (AMP) (Dynastream, Cochrane, Alberta, Canada) for 3 consecutive days during waking hours. The AMP is worn above the ankle in a neoprene pouch. Sensors within the AMP detect the angular velocity of the leg; an algorithm in the AMP calculates mean velocity and length of that stride. The AMP classifies activity into three categories: 1) Inactive: sitting, lying, or standing (i.e., when the wearer did not take any steps for at least 20 s), 2) Active: movement that includes those associated with daily tasks such as walking to a filing cabinet or cleaning house, or 3) Locomotion: intentional ambulation where the wearer took at least 20 consecutive steps (e.g., walking in the shopping mall). Within the active and locomotion categories, step count, average speed, average cadence, duration, and total distance traveled were calculated. Only data in the locomotion category are presented herein. Data were downloaded from the device to a computer using manufacturer-supplied software. Data were not normally distributed; therefore, the median and 25th and 75th percentiles were calculated. Independent treadmill testing has shown the AMP accurately reflects walking speeds between 0 and 6.9 km/h.

RESULTS

Participant characteristics were as follows: age 54.1 ± 7.7 years (50.3–57.8), BMI 33.4 ± 4.9 kg/m2 (31.0–35.7), and HbA1c 6.7 ± 0.9% (6.3–7.2) (means ± SD [95% CI]). Characteristics of walking in the locomotion category are shown in Table 1. The median speed of walking in locomotion was 3.3 km/h. Physical activity ranged from 4,508 to 29,979 steps/day, and locomotion walking speed ranged from 2.2 to 4.7 km/h; these variables were positively associated (r = 0.6, P = 0.01). All but one of the subjects walked ≥4.0 km/h for at least 1 min during the monitoring period.

CONCLUSIONS

The median walking speed of this cohort was 3.3 km/h and thus does not meet the walking speed commonly accepted as moderately intense physical activity (4). This is one of the first studies to directly measure self-paced walking speed in people with type 2 diabetes who have recently completed a behavior modification program intended to increase physical activity. The number of daily steps taken is close to a popular public health goal of 10,000 steps/day, and the time spent in locomotion approximates current recommendations for physical activity (9–11). The low walking speed observed in this study suggests that health benefits may not be fully achieved, even though participants approximate popular volume recommendations.

Although participants in this study walked at a slow absolute speed, it is possible their relative exertion reached 40–60% Vo2max. Relative intensity of walking was not measured in this study and is an important measurement to consider in future studies. The relative intensity of self-paced walking of individuals with type 2 diabetes is not known. The modest improvements in physiological outcomes achieved in the FSP suggest that self-paced walking in people with type 2 dia-betes may not approach the absolute intensity recommended for health benefits.

Numerous devices for monitoring ambulatory activity have been developed (12). The pedometer has gained wide acceptance as a cost-effective reliable measure of steps per day (13,14), but it has a limited ability to capture more extensive characteristics of walking such as speed. The AMP is a novel device suitable for collecting detailed ambulatory information, although it may be less accessible to a broad population due to its relatively high cost (∼$1,600 CDN) and the technical knowledge required to operate the device. Combining a pedometer with a stopwatch may be a feasible way to monitor walking speed.

The FSP employs the simple message of walk more steps per day. The slow walking speed observed (3.3 km/h) and the limited time spent at this intensity after completing the FSP suggests that this aspect of walking may need specific instruction in order to optimize health benefits derived from self-paced walking. If relative intensity appears to be a limiting factor, participants may benefit from additional conditioning to manage the demands of increased walking speeds.

View this table:
  • View inline
  • View popup
Table 1—

Median, 25th, and 75th percentiles of 3-day averaged ambulatory characteristics obtained from an AMP*

Acknowledgments

Funding for this study was provided by the Heart and Stroke Foundation, Alberta/North West Territories & Nunavut; Health Canada (Diabetes Strategy); and the Danone Institute of Canada.

The authors thank S.H. Choeng for his assistance in subject recruitment, Dr. Jeffery A. Johnson for statistical advice, and Dr. Normand Boule for reviewing early drafts of this manuscript. S.T.J. is a Canadian Institutes of Health Research strategic training fellow in TORCH (Tomorrow’s Research Cardiovascular Health Professionals).

Footnotes

  • A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

    • Accepted February 21, 2005.
    • Received February 18, 2005.
  • DIABETES CARE

References

  1. ↵
    Sigal RJ, Kenny GP, Wasserman DH, Castaneda-Sceppa C: Physical activity/exercise and type 2 diabetes. Diabetes Care 27:2518–2539, 2004
    OpenUrlFREE Full Text
  2. ↵
    U.S. Department of Health and Human Services: Physical Activity and Health: A Report of the Surgeon General. Atlanta, GA, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 1996
  3. ↵
    Siegel PZ, Brackbill RM, Heath GW: The epidemiology of walking for exercise: implications for promoting activity among sedentary groups. Am J Pub Health 85:706–710, 1995
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, Strath SJ, O’Brien WL, Bassett DR Jr, Schmitz KH, Emaplaincourt PO, Jacobs DR Jr, Leon AS: Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 32 (Suppl. 9):S498–S504, 2000
    OpenUrl
  5. ↵
    Boule NG, Haddad E, Kenny GP, Wells GA, Sigal RJ: Effects of exercise on glycemic control and body mass in type diabetes mellitus: a meta-analysis of controlled trials. JAMA 286:1218–1227, 2001
    OpenUrlCrossRefPubMedWeb of Science
  6. ↵
    Tudor-Locke CE, Myers AM, Bell RC, Harris SB, Rodger NW: Preliminary outcome evaluation of the First Step Program: a daily physical activity intervention for individuals with type 2 diabetes: Patient Educ Couns 47:23–28, 2002
    OpenUrlCrossRefPubMedWeb of Science
  7. ↵
    Tudor-Locke CE, Bell RC, Myers AM, Harris SB, Ecclestone NA, Lauzon N, Rodger NW: Controlled outcome evaluation of the First Step Program: a daily physical activity intervention for individuals with type 2 diabetes. Int J Obes Relat Metab Disord 28:113–119, 2004
    OpenUrlCrossRefPubMedWeb of Science
  8. ↵
    Chan CB, Ryan DA, Tudor-Locke C: Health benefits of a pedometer-based physical activity intervention in sedentary workers. Prev Med 39:1215–1222, 2004
    OpenUrlCrossRefPubMedWeb of Science
  9. ↵
    Health Canada: Canada’s Guide to Healthy Active Living. Ottawa, Government of Canada, 1998
  10. U.S. Department of Health and Human Services. Physical Activity and Health : A Report of the Surgeon General. Atlanta, GA, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Centre for Chronic Disease Prevention and Health Promotion, 1996
  11. ↵
    Pate RR, Pratt M, Blair SN, Haskell WL, Macera CA, Bouchard C, Buchner D, Ettinger W, King AC, et al: Physical activity and public health: a recommendation from the Centers for Disease Control and the American College of Sports Medicine. JAMA 273:402–407, 1995
    OpenUrlCrossRefPubMedWeb of Science
  12. ↵
    Tudor-Locke C, Myers AM: Challenges and opportunities for measuring physical activity in sedentary adults. Sports Med 31:91–100, 2001
    OpenUrlCrossRefPubMedWeb of Science
  13. ↵
    Tudor-Locke C, Myers AM: Methodological considerations for researchers and practitioners using pedometers to measure physical (ambulatory) activity. Res Q Exerc Sport 72:1–12, 2001
    OpenUrlCrossRefPubMedWeb of Science
  14. ↵
    Basset DR, Ainsworth BE, Leggett SR, Mathien CA, Main JA, Hunter DC, Duncan GE: Accuracy of five electronic pedometers for measuring distance walked. Med Sci Sports Exerc 28:1071–1077, 1996
    OpenUrlPubMedWeb of Science
PreviousNext
Back to top
Diabetes Care: 28 (6)

In this Issue

June 2005, 28(6)
  • Table of Contents
  • About the Cover
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Measuring Habitual Walking Speed of People With Type 2 Diabetes
(Your Name) has forwarded a page to you from Diabetes Care
(Your Name) thought you would like to see this page from the Diabetes Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Measuring Habitual Walking Speed of People With Type 2 Diabetes
Steven T. Johnson, Catrine Tudor-Locke, Linda J. McCargar, Rhonda C. Bell
Diabetes Care Jun 2005, 28 (6) 1503-1504; DOI: 10.2337/diacare.28.6.1503

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Measuring Habitual Walking Speed of People With Type 2 Diabetes
Steven T. Johnson, Catrine Tudor-Locke, Linda J. McCargar, Rhonda C. Bell
Diabetes Care Jun 2005, 28 (6) 1503-1504; DOI: 10.2337/diacare.28.6.1503
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • RESEARCH DESIGN AND METHODS
    • RESULTS
    • CONCLUSIONS
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Tables
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Increased Second Trimester Maternal Glucose Levels Are Related to Extremely Large-for-Gestational-Age Infants in Women With Type 1 Diabetes
  • The Effects of Hypogonadism on Body Composition and Bone Mineral Density in Type 2 Diabetic Patients
  • Effect of Renal Insufficiency on the Pharmacokinetics of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor
Show more Clinical Care/Education/Nutrition

Similar Articles

Navigate

  • Current Issue
  • Standards of Care Guidelines
  • Online Ahead of Print
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Care Print ISSN: 0149-5992, Online ISSN: 1935-5548.